Khorionyx is a R&D biomedical company founded in 2003 with the objective of developing innovative medical applications based on human globin.

Globin is the protein derived from human hemoglobin after removal of its red pigment. Globin is insoluble in physiological conditions and shares many other similar biological properties with collagen. Human globin also brings other unique properties to develop innovative bioactive implants.

Peripheral blood is the most accessible human tissue, from which globin can be quickly and easily prepared. This makes it particularly attractive as a source of autologous biomaterials.

The first priority of Khorionyx is to develop the aesthetic application of the autologous globin dermal filler for soft tissue augmentation. Other medical applications are possible in significant markets like wound healing or bone repair.

Globin can also be used to prepare composite biomaterials to improve their biocompatibility and biointegration.